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Purpose: 3 T late gadolinium enhancement (LGE) imaging is expected to provide 
comparable image quality to 1.5 T even with reduction of gadolinium contrast, 
thanks to superior signal to noise ratio and longer T1 relaxation time of normal 
myocardium. This prospective study was designed to perform intra-individual 
comparison of 3 T MR with use of 0.1 mmol/kg of gadoterate meglumine to 1.5 T 
MR with use of 0.2 mmol/kg of the same gadolinium contrast for the assessment of 
myocardial infarction.  
Materials and Methods: In this prospective study, a total of ten patients (M:F = 
8:2; mean age, 62.5 ± 11.8 years) diagnosed as old myocardial infarction were 
examined at 3 T MR with single dose within two weeks after 1.5 T conventional 
double dose MR. A single representative short-axis image was acquired at three-
time point temporal scans (10 minute, 15 minute and 20 minute) after 
ii 
administration of gadolinium agent (Uniray, gadoterate meglumine, Dongkook 
Pharmaceutical Co., Ltd). Two contrast to noise ratios (CNRs) between infarcted 
and normal myocardium and between infarcted and left ventricular (LV) cavity 
were calculated and compared intra-individually at each temporal scan. Two 
independent readers assessed infarct size semiautomatically by using a threshold of 
6 standard deviations above the mean signal intensity of the remote myocardium. 
The interobserver reproducibility was also evaluated using intraclass correlation 
coefficient (ICC). 
Results: Despite the usage of single dose of gadolinium, the mean values of infarcted 
myocardium tended to be higher at 3 T MR than 1.5 T MR with double dose at each 
time scan. 3 T LGE images with the single dose of gadolinium showed no significant 
difference in CNR between infarcted and normal myocardium at each time scan (all, 
p > 0.05). The CNR between infarcted myocardium and LV cavity was significantly 
better at 10 minute scan, compared to that of 1.5 T double dose (12.4 ± 8.2 vs. 7.6 ± 
4.5, p = 0.049) but there were no differences at 15 and 20 minute scan. The 
measurement of relative infarct size was not significantly different between 1.5 T 
and 3 T MR by both observers 1 and 2 (all, p > 0.05). Interobserver reproducibility 
was excellent at 3 T single-dose MR (ICC range: 0.962-0.968) and good or excellent 
at 1.5 T double-dose MR (ICC range: 0.769-0.866). 
Conclusions: LGE imaging at 3 T with single-dose contrast is as effective as 1.5 T 
conventional double-dose MR for the delineation of infarcted myocardium from 
non-infarcted myocardium and is superior for detection of infarcted myocardium 
from blood cavity at 10 minute scan. Therefore, 3 T LGE imaging using a single 
dose of gadolinium is expected to not only reduce risk of nephrogenic systemic 
fibrosis but also help to delineate subendocardial infarction. 
iii 
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Cardiac magnetic resonance (CMR) imaging with late gadolinium enhancement 
(LGE) is widely considered as a gold standard for assessment of myocardial 
viability with high spatial resolution and has been proven to accurate correlation in 
comparison to the histopathologic results by triphenyltetrazolium chloride (TTC) 
stain in animal experiments (1-7). Recovery of contractibility of the hypokinetic 
segments of the ischemic myocardium can be predicted by CMR imaging by 
estimating transmurality of myocardial infarction, which is critical to guide 
revascularization therapy and prognostic prediction. Gadolinium-based agents have 
been generally used for delayed enhancement images of CMR. In acute or chronic 
condition of myocardial infarction, extracellular space is relatively increased and 
therefore, nonspecific extracellular gadolinium chelates could be more 
accumulated within the extracellular space, compared to the intact normal 
myocardial area. While the concentration of gadolinium in normal myocardium is 
washed out earlier, greater amount of gadolinium stays longer in the infarcted 
tissue. Consequently, it provides an opportunity for optimal visualization of the 
infarcted areas (1, 8-10). Up to now, CMR imaging has been predominantly 
performed at 1.5 Tesla (T), yielding clinically acceptable image quality. However, 
all of those studies with LGE were validated at 1.5 T MR with a conventional 
double-dose (0.2 mmol/kg) or more of gadolinium contrast agents, which exceeded 
the label-recommended dose (11). Unfortunately, the free gadolinium ions, released 
from gadolinium complexes, are known to have a high level of potential toxicity. 
Many current publications have proven dose-related association between 
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gadolinium-based contrast agents and nephrogenic systemic fibrosis (NSF) (12-
17). 
In recent years, commercially available MR systems with a higher 
magnetic field strength (3 T) and dedicated multi-element coils have become 
available for clinical applications. CMR imaging with LGE aided by the 
advantages of high-field strength imaging is expected to provide the capability to 
distinguish between the viable, hibernating and infarcted myocardium with high 
sensitivity and with strong pathophysiologic correlation (7). Although the problems 
derived from high field strength exist at 3 T, concerning amplified susceptibility 
artifacts, increased radiofrequency field inhomogeneity, dielectric resonance effects 
and higher specific absorption rate (SAR), 3 T CMR is currently considered as a 
promising tool for many clinical applications (18-20). Most of all, the major 
advantage in imaging at a higher field strength is attributed to an improvement in 
signal to noise (SNR). The signal intensity (SI) of MR generally shows quadratic 
increase as the static magnetic field strength (B0) increases, while the noise exhibits 
the linear B0 dependence. Therefore, a gain of doubled SNR would be expected 
when increasing the main magnetic field strength from 1.5 T to 3 T (18, 21). With 
an increase in the field strength from 1.5 T to 3 T, the longitudinal relaxation time 
(T1) of most tissues increases with the third root of the field strength (22). As 
normal myocardium at 3 T recovers more slowly, requiring longer TI, particularly 
on LGE imaging, the absolute signal difference between normal and infarcted 
myocardium can be maximized (22, 23). Hence, even with the reduced dose of 
gadolinium contrast 3 T MR with LGE is anticipated to provide comparable image 
quality to 1.5 T as well as to decrease the risk of NSF. 
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Many prior studies assessing image quality of LGE imaging at 1.5 T MR 
with the reduced dosage (0.1 mmol/kg or 0.15 mmol/kg) have achieved 
comparable image quality, owing to better delineation between the LV cavity and 
the infarcted myocardium compared to that with conventional double dose (11, 24-
31). Until now, however, there has been very few study with 3 T MR using a single 
dose to evaluate either image quality or even infarct area quantification (32). In 
previous animal and human studies with 3 T CMR, various dosage of gadolinium 
contrast agents (ranging from 0.05 mmol/kg to 0.2 mmol/kg) (19, 32-35) have been 
empirically used. Feasibility of single dose of gadolinium at 3 T has not been 
validated yet.  
Therefore, we hypothesized that 3 T CMR imaging with single-dose 
gadolinium agents would provide comparable CNR between infarcted and normal 
myocardium and better CNR between LV cavity and normal myocardium, and also 
the quantification of infarcted area would present high reproducibility subsequently 
due to better CNR between LV cavity and normal myocardium.  
This prospective study was designed to perform intra-individual 
comparison of 3 T MR with use of 0.1 mmol/kg of gadoterate meglumine to 1.5 T 
MR with use of 0.2 mmol/kg of the same gadolinium contrast agent for assessment 
of myocardial infarction.  
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MATERIALS AND METHODS 
 
The institutional review board of our hospital approved this prospective study and 




All patients who were diagnosed as old myocardial infarction proven by the 
previous CMRs (32, 36) and referred to the Department of Radiology of our 
hospital for CMR were eligible for recruitment into this prospective study. 
Exclusion criteria were any renal impairment (glomerular filtration rate under 60 
mL/min), known hypersensitivity to gadolinium agents, and general 
contraindications to MR imaging, including cardiac pacemaker, metal clips, and 
claustrophobia. A total of ten patients (M:F = 8:2; mean age, 62.5 ± 11.8 years; age 
range, 44-77 years) have been successfully enrolled, who underwent imaging at 1.5 
T MR with conventional double dose first, followed by imaging at 3 T with single 
dose within two weeks. 
 
MRI Protocol 
All MR examinations were performed in both 1.5-Tesla MR scanner (Magnetom 
Sonata; Siemens Medical solutions, Erlangen, Germany) and 3-Tesla MR scanner 
(Trio; Siemens Medical Solutions, Erlangen, Germany) for all patients. All MR 
images were acquired during repeated end-expiratory breath-holds and were 
electrocardiographically retrospective gated. 
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After performing the scout images, LGE images were obtained with an 
inversion recovery (IR) turbo fast low-angle shot (FLASH) sequence that produces 
both magnitude-reconstructed and phase-sensitive images in both 1.5 T and 3 T 
MR scanners. We adjusted the scan parameters to be identical between two 
examinations for optimal comparison and the parallel imaging technique was not 
applied on both scans. The detailed scan parameters are listed in the Table 1. A 
single dose (0.1 mmol/kg) of gadolinium agent (Uniray, gadoterate meglumine, 
Dongkook Pharmaceutical Co., Ltd) for 3 T MR and double dose (0.2 mmol/kg) of 
for 1.5 T MR were injected at a flow rate of 2.0 ml/s followed by a saline flush of 
20 ml at the same flow rate. After reviewing the each patient’s previous CMRs, one 
radiologist (J.Y.L) selected the single representative short axis slice that best 
presented LGE of the infarcted myocardium in advance, and the selected short axis 
slice was identically performed at both 3 T and 1.5 T MR at 10, 15 and 20 minutes 
after contrast administration. The optimal inversion time (TI) was determined using 
a TI scout (TR/TE, 25/1.1 msec; flip angle, 50°; slice thickness, 8 mm; matrix: 192 
 72; in-plane resolution 4.8-1.4 mm2; different TIs from 80-804 msec, 31 images 
for 1.5 T, TR/TE, 29/1.5 msec; flip angle, 35°; slice thickness, 8 mm; matrix: 192  
78; in-plane resolution 3.8-1.2 mm2; different TIs from 100-1007 msec, 26 images 
for 3 T), adjusted to obtain the maximal contrast between viable and infarcted 
myocardium at each temporal scan (TI range, 10 minute: 250-290 msec, 15 minute 
250-310 msec, 20 minute: 300-330 msec for 1.5 T, 10 minute: 400-450, 15 minute: 
420-470 msec, 20 minute: 450-480 msec for 3 T).  
 
MR Image Analysis 
6 
Image Quality Assessment 
On the short axis magnitude images, circular regions of interest (ROIs) were 
defined by one observer (J.Y.L) within the infarcted myocardium, remote normal 
myocardium and LV cavity. The mean values of SI values were measured within 
these regions. Noise was derived from the standard deviation (SD) of the SI of an 
ROI located in the background air (Figure 1). These ROIs were placed at the 
corresponding locations on the representative short axis images of both MR 
examinations. The CNR between the infarcted myocardium and normal 
myocardium (CNRinfarct-normal) was calculated using the following equation: 
CNRinfarct-normal = SIinfarcted myocardium - SInormal myocardium / noise. The CNR between the 
infarcted myocardium and LV cavity (CNRinfarct-LVC) was calculated using this 
following equation: CNRinfarct-LVC = SIinfarcted myocardium - SILV cavity / noise), in which SI 
indicates the mean SI of an ROI located in each anatomic region. All processes 
were performed on a picture archiving and communication system (PACS; Infinitt, 
Seoul, Korea) workstation. 
Infarct Quantification 
Two experienced observers (E.A.P. and J.Y.L with 10 and 4 years of experience in 
CMR interpretation, respectively), blind to the field strength and the dosage of 
gadolinium contrast agent independently measured the area of LGE on the 
magnitude images in a random order by using the dedicated semiautomatic analysis 
program (CMR42 Version 4.1, Circle Cardiovascular Imaging Inc., Calgary, 
Canada). As Figure 1 depicted, epicardial and endocardial contours and a ROI 
placed in remote, unenhanced myocardium were outlined manually twice by two 
observers, and the LGE area are defined by means of a threshold of 6 SD above the 
mean SI of remote, non-enhanced myocardium according to the previous studies 
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(26, 36-38). The papillary muscles and trabeculations were equally excluded on all 
ROIs. Based on the LGE measurements, the software program calculated the 
relative infarct size, which was expressed as percentage of the total left ventricular 
myocardium. 
 
Statistical Analysis  
The quantitative results of the two examinations were compared with each other 
using paired two-tailed Student t test after data distributions were examined for 
normality using the Kolmogorov-Smirnov test. Normally distributed data were 
expressed as the mean ± standard deviation. Interobserver reproducibility for the 
measurement of relative infarct size was evaluated by intraclass correlation 
coefficient (ICC) generated by a two-way random-effects model with an absolute 
agreement definition (0.0-0.40, poor; 0.41-0.60, moderate; 0.61-0.80, good; and 
0.81-1.00, excellent correlation) (39) and Bland-Altman analysis. All statistical 
analyses were performed using SPSS version 17.0 (SPSS Inc., Chicago, IL). 




Details of demographic and clinical characteristics of all patients are listed in the 
Table 2. Scanning at both field strengths was well tolerated by all patients, and all 
images were acquired of sufficient quality for analysis. No problems with breath 
holding nor electrocardiographic gating were encountered.  
 
Image Quality Assessment 
The results of SI of the infarcted and normal myocardium and LV cavity are 
demonstrated in Table 3 in detail. Despite the usage of single dose of gadolinium, 
mean values of SIs of infarcted regions tended to be twice higher at each time scan 
at 3 T MR than 1.5 T MR with double dose but the statistical significance did not 
reach (all, p > 0.05). Also, all of the SIs of normal myocardium and LV cavity 
tended to be higher at 3 T than 1.5 T MR (Table 3 and Figure 2).  
3 T LGE images with the single dose of gadolinium showed no significant 
difference in CNR between infarcted and normal myocardium at each time scan 
(all, p > 0.05). At 3 T MR with the single dose of gadolinium, the CNR between 
infarcted myocardium and LV cavity was significantly better at 10 minute scan, 
compared to double-dose 1.5 T MR. Even though they were statistically 
insignificant, 3 T LGE images also showed a tendency toward higher CNR 
between infarcted myocardium and LV cavity at both 15 minute and 20 minute 





There was no difference in relative infarct size between 1.5 T with double-dose and 
3 T with single-dose images (Table 5). Bland-Altman analysis (Figure 5) indicated 
that both MR exams had good agreement in measuring relative infarct size by 
observer 1 (mean bias, -0.8% ± 10.8, range -21.9 to 20.3%) and observer 2 (mean 
bias, 5.8% ± 10.0, range -13.9 to 25.5%). Table 6 summarized the ICC values 
between observers 1 and 2 regarding interobserver reproducibility for the 
quantification of relative infarct size. Interobserver agreement was excellent in all 
three time point scans at 3 T single-dose MR with statistical significance. On the 




Table 1. Scan parameters of MR 
 
 1.5 T 3 T 
FOV (mm) 271 x 300 271 x 300 
Pixel size (mm) 1.2 x 1.8 1.2 x 1.8 
Section thickness (mm) 6  6  
Repetition time (msec) 8.8  5.3  
Echo time (msec) 4.2  2  
Flip angle (degree) 25 13 
Scan time (sec) 12-17 7-13 
Parallel imaging Not applied Not applied 
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Table 2. Patient characteristics 
Note. LV = left ventricle 
Patient characteristics n = 10 
Age (years) 
Gender (M/F) 









Prior coronary artery bypass graft 
Ejection fraction (%) 
End-diastolic volume (ml/m2) 
End-systolic volume (ml/m2) 
Average LV myocardial mass (g) 












38.1 ± 8.6 
120.9 ± 32.0 
76.3 ± 26.0 
138.0 ± 51.0 
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Table 3. Signal intensity of 1.5 T double-dose and 3 T single-dose images (n = 
10) 
Note. Data are presented as means ± standard deviations. 
SI = Signal intensity 
LVC = Left ventricular cavity 
 1.5 T Double-dose 3 T Single-dose p value 




47.9 ± 15.8 
45.1 ± 14.8 
48.1 ± 17.2 
82.5 ± 29.0 
88.3 ± 36.0 





     10 minute 
     15 minute 
     20 minute 
SILVC 
10 minute 
     15 minute 
     20 minute 
 
6.6 ± 1.7 
6.6 ± 1.4 
6.9 ± 1.8 
 
39.0 ± 13.4 
32.1 ± 13.2 
34.4 ± 14.4 
 
12.8 ± 7.4 
11.5 ± 5.9 
12.2 ± 7.3 
 
59.6 ± 31.2 
56.3 ± 28.4 










Table 4. Comparison of CNR between 1.5 T double-dose and 3 T single-dose 
images (n = 10） 
Note. Data are presented as means ± standard deviations. 
CNR = Contrast to noise ratio 
LVC = Left ventricular cavity 
 1.5 T Double-dose 3 T Single-dose p value 




35.4 ± 12.1 
36.9 ± 12.2 
40.6 ± 14.5 
37.7 ± 10.9 
37.6 ± 12.4 





     10 minute 
     15 minute 
     20 minute 
 
7.6 ± 4.5 
12.4 ± 5.9 
14.3 ± 7.3 
 
12.4 ± 8.2 
16.1 ± 9.2 






Table 5. Quantification of relative infarct size (%) measured by observer 1 and 
2 (n = 10)






 1.5 T double-dose 3 T single-dose p value 
Observer 1 
10 minute 
   15 minute 
   20 minute 
Observer 2 
10 minute 
   15 minute 
   20 minute 
 
27.7 ± 10.4 
28.5 ± 13.2 
28.1 ± 8.1 
 
33.8 ±10.7 
37.2 ± 10.5 
36.1 ± 12.0 
 
27.1 ± 11.7 
30.9 ± 14.4 
28.8 ± 8.1 
 
29.0 ± 11.6 
31.2 ± 12.8 










Table 6. Interobserver reproducibility between 1.5 T double-dose and 3 T single-
dose exams




 Intraclass correlation coefficient (95% CI) 










  0.962 (0.962-0.990) 
  0.968 (0.873-0.992) 















Figure 1. Assessment of SIs, CNR and infarct size on magnitude images. (A, B) 
SIs were determined in circular ROIs placed in remote normal and infarcted 
myocardium, and LV cavity. Noise was derived from the ROI located in the 
background air. (C) Assessment of infarct size of LGE by using the semiautomatic 
analysis software. A small blue circle indicates reference myocardium as normal 
remote myocardium. The infarct size was quantified by identifying myocardial 
areas with LGE, overlaid with yellow color, by means of a threshold of 6 SD above 
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Figure 2. Box and Whisker plot shows the SIs of infarcted myocardium (A), 
remote unenhanced myocardium (B), LV cavity (C), CNRinfarct-normal (D) and 
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Figure 3. 71-year-old man. Delineation of the subendocardial infarction on LGE 
images with a 1.5 T double dose (A, B, C) and 3 T single dose (D, E, F) of 
gadolinium contrast agent. It is hard to delineate the border between 
subendocardial infarction and LV cavity because the bright blood cavity obscures 
subendocardial infarction at 1.5 T. On the other hand, delineation of endocardial 








Figure 4. 59-year-old man. Delineation of the subendocardial infarction on LGE 
images with a 1.5 T double dose (A, B, C) and 3 T single dose (D, E, F) of 
gadolinium contrast agent. The greater signal difference between LV cavity and the 
subendocardial infarcted region on 3 T MR (D, E, F) enables to better delineation 











Figure 5. Bland-Altman analysis of relative infarct size measured by observer 1 
and 2. Solid line = mean difference. Dashed lines = upper and lower limits of 
agreement. 














































































This study is the first to demonstrate the feasibility of single dose 3 T MR, 
compared to double dose 1.5 T MR. The principal findings from our results can be 
summarized as follows: (a) CNR between the infarcted and normal myocardium at 
3 T with single dose MR was comparable to that of 1.5 T. (b) CNR between 
infarcted myocardium and blood cavity was significantly higher at 10 minute scan 
of 3 T with single dose contrast than 1.5 T with double dose. (c) Regarding 
quantitatitive assessment of relative infarct size, 3 T MR showed excellent ICC 
values, while ICC values were good or excellent at 1.5 T MR. 
Currently, technical advances that enhance the ability of MRI after 
administration of gadolinium based contrast agents have allowed to visualize 
pathological changes in the heart with enhanced spatial and temporal resolution 
and can improve the diagnostic capability of this modality for the diagnosis and 
characterization of myocardial infarction (1). Furthermore, CMR with LGE at 
higher magnetic field strength is a promising tool, which is beneficial for 
evaluation of myocardial viability, with a growing number of 3 T MR scanners 
being installed worldwide. In fact, recent studies have demonstrated notable 
improvement in image quality, SNR and CNR of LGE MR imaging at 3 T over 1.5 
T (19, 40). One of the most appealing advantage of imaging at 3 T MR is a 
substantial gain in SNR (18), which may also be interpreted into an improvement 
in CNR between enhancing blood pool and non-enhancing background (41).  
As the longitudinal relaxation time of unenhanced blood or background 
tissue substantially increases with field strength the signal recovery of those tissue 
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occurs more slowly at higher magnetization field, the T1 shortening effect of 
gadolinium agents may become more heightened, because the relaxivity of those 
contrast agents is only minorly affected between 1.5 T and 3 T magnetic fields. 
Accordingly, the increased efficacy of administrated gadolinium agents at 3 T 
allows to reduce the amount contrast agents without deteriorating the image 
quality, in theory. MR studies using single-dose gadolinium at 3 T have been 
validated in the field of angiography but there was no validation study for the 
evaluation of myocardial infarction to date. Similar to the design of our study, 
Herborn et al. (42) compared between single-dose contrast-enhanced MR renal 
angiography at 3 T and double-dose MR angiography at 1.5 T intraindividually and 
they proved that the difference in mean image quality was not statistically 
significant. Also, Kramer et al. (43) also demonstrated the feasibility of single-
dose, time-resolved contrast-enhanced 3D MR angiography in assessment of the 
abdominal aorta and its major branches at 3 T. In particular, of our results, even 
though we reduced the dose of gadolinium contrast agent by half when performing 
3 T MR imaging, all of the SIs of the infarcted and normal myocardium and the LV 
cavity in each time scan tended to be higher than those of 1.5 T double dose 
images. The major elements affecting these results can be explained as follows; (a) 
a gain of doubled SNR at 3 T (18), and (b) prolonged T1 relaxation time of the 
normal myocardium and increase in the efficacy of T1 shortening effect of 
gadolinium agents may result in maximizing the signal difference between the 
normal and infarcted myocardium (22, 23). 
Conventionally, a double dose of contrast agent has been used because 
LGE was originally validated by animal experimental studies using a double dose 
of gadolinium contrast agent and the subsequent clinical studies were performed 
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using the same dose establishing substantially high image quality and diagnostic 
accuracy (1, 7, 10, 31, 44-47). However, it is an important issue in fact that 
gadolinium-based contrast agents may trigger the development of an extremely rare 
but serious complication, nephrogenic systemic fibrosis (NSF). In 2010, the U.S. 
FDA announced that label-recommended dose of the conventional gadolinium 
based-contrast agent (generally 0.1 mmol/kg) should not be exceeded in any 
patients (11). As gadolinium has to be chelated with appropriate ligands to be 
allowed to clinical use, these gadolinium complexes are linear or macrocyclic. Of 
various gadolinium-based contrast agents, gadoterate meglumine (Gd-DOTA) has 
the highest thermodynamic stability (log10 KTHERM = 25.6), apparent stability 
(log10Kcond = 19.3), pharmacokinetic stability, and decomplexation of all available 
gadolinium-chelate agents (48, 49). Uniray (gadoterate meglumine, Dongkook 
Pharmaceutical Co., Ltd.), used for LGE in our study, is a macrocyclic ionic 
gadolinium-based contrast agent as well as a generic agent of Dotarem (gadoterate 
meglumine, Guerbet, Roissy CdG, France). It has been proven very safe even in 
the high-risk patients with impaired renal function and so far, to our knowledge, no 
validated cases of NSF have been documented yet, solely attributed to Gd-DOTA 
(48, 50-51). In this study, none of all patients have shown any sign of NSF and 
other adverse effects up to now. 
There is another major concern in terms of the usage of a double dose of 
gadolinium contrast agents: brightened blood cavity may lead to obscure 
subendocardial infarction (8). This is a critical obstacle in detection of 
subendocardial infarction and in estimation of the exact infarct size some parts of 
subendocardial infarction may be misinterpreted as the LV cavity. According to a 
recent study reported by Kim et al. (24), they compared LGE images at 1.5 T MR 
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with single dose versus double dose, and found that CNR between the infarcted 
myocardium and LV cavity exhibited negative value when a double dose of 
gadolinium agent was used, which indicated that the LV cavity blood was much 
brighter than the infarcted myocardium. Also in our results, as we initially 
hypothesized, the CNR between the infarcted myocardium and the LV cavity was 
significantly higher at 10 minute exam at 3 T with single dose than at 1.5 T with a 
double dose of contrast agent. On the other hand, at 15 and 20 minute scans, CNR 
between the infarcted myocardium and the LV cavity was not significantly 
different, even though it showed a tendency to be higher at 3 T MR than 1.5 T MR. 
It suggests that bright blood cavity could be overcome by more delayed scan at 
double-dose 1.5 T but this can be a disadvantage due to longer scan time in clinical 
practice. Our results from the measurement of relative infarct size did not show any 
significant difference between two observers at both field strengths. Particularly, 
using 3 T MR, the quantification of infarcted area presented excellent interobserver 
agreement at each temporal scan. We suggested that it is because the more decrease 
in brightness of the LV cavity at 3 T MR with single dose than 1.5 T with double 
dose allowed accurate demarcation of the endocardial contour of infarcted area. 
Therefore, we finally suggest that the 3 T CMR imaging with single dose 
gadolinium agents can be feasible in clinical practice and has sufficient capability 
of the detection and precise quantitative measurement of myocardial infarction. 
We recognize that the present study has several limitations. Major 
limitation is a small number of population for an adequate statistical work-up. 
Second, this study is a single center study. Third, to maintain the patent cohort 
uniformly, we only included the patients who diagnosed as old myocardial 
infarction confirmed by previous MR studies. Because the pathologic and patient 
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status are different between acute and chronic myocardial infarction, our results 
cannot be extrapolated in a group of acute myocardial infarction. Fourth, we did 
not evaluated diagnostic accuracy and detectability of LGE, because in all patients 
recruited in our study the presence of LGE regions was already confirmed on 
previous MR exams. Lastly, we only analyzed the magnitude images for the 
evaluation of the image quality. As the magnitude-reconstructed image is highly 
sensitive to the inversion recovery time, an error in selecting the precise nulling 
time can lead to a reduction in contrast between normal myocardium and 
enhancing tissue. Therefore, we determined the optimal nulling time of normal 
myocardium according to the TI scout performed only a few seconds before every 
temporal scan. We believe that optimal adjustment of TI could avoid any 
significant bias on the contrast of the magnitude images. In addition, since the 
phase-sensitive inversion recovery (PSIR) reconstruction fundamentally 
implements the process of spatial smoothing, applied to reduce the noise of 
reference image, the value of noise on PSIR images is known to not to indicate the 




LGE imaging at 3 T with single dose contrast is as effective as 1.5 T conventional 
double dose MR for delineation of the infarcted myocardium from the non-
infarcted myocardium and is superior for detection of the infarcted myocardium 
from the blood cavity. Therefore, 3 T LGE imaging using a single dose of 
gadolinium is expected to not only reduce the risk of NSF but also might help to 




This research was supported by grant no 06-2013-1390 from Dong-Kook 




1. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic 
resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 
2000;343(20):1445-53. 
2. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-
motion abnormalities predicted by positron tomography. N Engl J Med. 
1986;314(14):884-8. 
3. Braunwald E, Rutherford JD. Reversible ischemic left ventricular 
dysfunction: evidence for the "hibernating myocardium". Journal of the American 
College of Cardiology. 1986;8(6):1467-70. 
4. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved 
outcome after coronary bypass surgery in patients with ischemic cardiomyopathy 
and residual myocardial viability. Circulation. 1997;96(3):793-800. 
5. Perrone-Filardi P, Pace L, Prastaro M, et al. Assessment of myocardial 
viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl 
tomography versus dobutamine echocardiography. Circulation. 1996;94(11):2712-9. 
6. Chaudhry FA, Tauke JT, Alessandrini RS, Vardi G, Parker MA, Bonow RO. 
Prognostic implications of myocardial contractile reserve in patients with coronary 
artery disease and left ventricular dysfunction. Journal of the American College of 
Cardiology. 1999;34(3):730-8. 
7. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast 
enhancement to irreversible injury, infarct age, and contractile function. Circulation. 
1999;100(19):1992-2002. 
32 
8. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement 
imaging. J Cardiovasc Magn Reson. 2003;5(3):505-14. 
9. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed 
enhancement cardiovascular magnetic resonance assessment of non-ischaemic 
cardiomyopathies. Eur Heart J. 2005;26(15):1461-74. 
10. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. 
Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction 
between reversible and irreversible injury throughout infarct healing. Journal of the 
American College of Cardiology. 2000;36(6):1985-91. 
11. Nacif MS, Arai AE, Lima JA, Bluemke DA. Gadolinium-enhanced 
cardiovascular magnetic resonance: administered dose in relationship to United 
States Food and Drug Administration (FDA) guidelines. J Cardiovasc Magn Reson. 
2012;14:18. 
12. Thomsen HS, Marckmann P, Logager VB. Nephrogenic systemic fibrosis 
(NSF): a late adverse reaction to some of the gadolinium based contrast agents. 
Cancer imaging : the official publication of the International Cancer Imaging Society. 
2007;7:130-7. 
13. DeHoratius DM, Cowper SE. Nephrogenic systemic fibrosis: an emerging 
threat among renal patients. Seminars in dialysis. 2006;19(3):191-4. 
14. Cowper SE. Nephrogenic fibrosing dermopathy: the first 6 years. Current 
opinion in rheumatology. 2003;15(6):785-90. 
15. Scheinfeld N. Nephrogenic fibrosing dermopathy: a comprehensive review 
for the dermatologist. American journal of clinical dermatology. 2006;7(4):237-47. 
16. Abujudeh HH, Kaewlai R, Kagan A, et al. Nephrogenic systemic fibrosis 
after gadopentetate dimeglumine exposure: case series of 36 patients. Radiology. 
33 
2009;253(1):81-9. 
17. Grobner T. Gadolinium--a specific trigger for the development of 
nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrology, 
dialysis, transplantation : official publication of the European Dialysis and 
Transplant Association - European Renal Association. 2006;21(4):1104-8. 
18. Wieben O, Francois C, Reeder SB. Cardiac MRI of ischemic heart disease 
at 3 T: potential and challenges. Eur J Radiol. 2008;65(1):15-28. 
19. Klumpp B, Fenchel M, Hoevelborn T, et al. Assessment of myocardial 
viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla. Invest 
Radiol. 2006;41(9):661-7. 
20. Schar M, Kozerke S, Fischer SE, Boesiger P. Cardiac SSFP imaging at 3 
Tesla. Magnetic resonance in medicine : official journal of the Society of Magnetic 
Resonance in Medicine / Society of Magnetic Resonance in Medicine. 
2004;51(4):799-806. 
21. Fenchel M, Kramer U, Nael K, Miller S. Cardiac magnetic resonance 
imaging at 3.0 T. Topics in magnetic resonance imaging : TMRI. 2007;18(2):95-104. 
22. Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM. A review of normal 
tissue hydrogen NMR relaxation times and relaxation mechanisms from 1–100 MHz: 
dependence on tissue type, NMR frequency, temperature, species, excision, and age. 
Medical physics. 1984;11(4):425-48. 
23. Haacke EM, Brown RW, Thompson MR, Venkatesan R. Magnetic 
resonance imaging. Physical principles and sequence design. 1999. 
24. Kim YK, Park EA, Lee W, Kim SY, Chung JW. Late gadolinium 
enhancement magnetic resonance imaging for the assessment of myocardial 
infarction: comparison of image quality between single and double doses of contrast 
34 
agents. The international journal of cardiovascular imaging. 2014. 
25. Balci NC, Inan N, Anik Y, Erturk MS, Ural D, Demirci A. Low-dose 
gadobenate dimeglumine versus conventional-dose gadopentate dimeglumine for 
delayed contrast-enhanced cardiac magnetic resonance imaging. Academic 
radiology. 2006;13(7):833-9. 
26. De Cobelli F, Esposito A, Perseghin G, et al. Intraindividual comparison of 
gadobutrol and gadopentetate dimeglumine for detection of myocardial late 
enhancement in cardiac MRI. AJR American journal of roentgenology. 
2012;198(4):809-16. 
27. Bauner KU, Reiser MF, Huber AM. Low dose gadobenate dimeglumine for 
imaging of chronic myocardial infarction in comparison with conventional dose 
gadopentetate dimeglumine. Invest Radiol. 2009;44(2):95-104. 
28. Wagner A, Mahrholdt H, Thomson L, et al. Effects of time, dose, and 
inversion time for acute myocardial infarct size measurements based on magnetic 
resonance imaging-delayed contrast enhancement. Journal of the American College 
of Cardiology. 2006;47(10):2027-33. 
29. Durmus T, Schilling R, Doeblin P, et al. Gadobutrol for magnetic resonance 
imaging of chronic myocardial infarction: intraindividual comparison with 
gadopentetate dimeglumine. Invest Radiol. 2012;47(3):183-8. 
30. Nacif MS, Kawel N, Lee JJ, et al. Interstitial myocardial fibrosis assessed 
as extracellular volume fraction with low-radiation-dose cardiac CT. Radiology. 
2012;264(3):876-83. 
31. Kim RJ, Albert TS, Wible JH, et al. Performance of delayed-enhancement 
magnetic resonance imaging with gadoversetamide contrast for the detection and 
assessment of myocardial infarction: an international, multicenter, double-blinded, 
35 
randomized trial. Circulation. 2008;117(5):629-37. 
32. Cheng AS, Robson MD, Neubauer S, Selvanayagam JB. Irreversible 
myocardial injury: assessment with cardiovascular delayed-enhancement MR 
imaging and comparison of 1.5 and 3.0 T--initial experience. Radiology. 
2007;242(3):735-42. 
33. Huber A, Bauner K, Wintersperger BJ, et al. Phase-sensitive inversion 
recovery (PSIR) single-shot TrueFISP for assessment of myocardial infarction at 3 
tesla. Invest Radiol. 2006;41(2):148-53. 
34. Gebker R, Jahnke C, Paetsch I, et al. Diagnostic performance of myocardial 
perfusion MR at 3 T in patients with coronary artery disease. Radiology. 
2008;247(1):57-63. 
35. Kino A, Zuehlsdorff S, Sheehan JJ, et al. Three-dimensional phase-
sensitive inversion-recovery turbo FLASH sequence for the evaluation of left 
ventricular myocardial scar. AJR American journal of roentgenology. 
2009;193(5):W381-8. 
36. Flett AS, Hasleton J, Cook C, et al. Evaluation of techniques for the 
quantification of myocardial scar of differing etiology using cardiac magnetic 
resonance. JACC Cardiovasc Imaging. 2011;4(2):150-6. 
37. Beek AM, Bondarenko O, Afsharzada F, van Rossum AC. Quantification 
of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart 
disease: a comparison to functional outcome. J Cardiovasc Magn Reson. 2009;11:6. 
38. Harrigan CJ, Peters DC, Gibson CM, et al. Hypertrophic cardiomyopathy: 
quantification of late gadolinium enhancement with contrast-enhanced 
cardiovascular MR imaging. Radiology. 2011;258(1):128-33. 
39. Song YS, Choi SH, Park CK, et al. True progression versus 
36 
pseudoprogression in the treatment of glioblastomas: a comparison study of 
normalized cerebral blood volume and apparent diffusion coefficient by histogram 
analysis. Korean journal of radiology : official journal of the Korean Radiological 
Society. 2013;14(4):662-72. 
40. Gutberlet M, Noeske R, Schwinge K, Freyhardt P, Felix R, Niendorf T. 
Comprehensive cardiac magnetic resonance imaging at 3.0 Tesla: feasibility and 
implications for clinical applications. Invest Radiol. 2006;41(2):154-67. 
41. Schmitt F, Grosu D, Mohr C, et al. [3 Tesla MRI: successful results with 
higher field strengths]. Der Radiologe. 2004;44(1):31-47. 
42. Herborn CU, Runge VM, Watkins DM, Gendron JM, Naul LG. MR 
angiography of the renal arteries: intraindividual comparison of double-dose contrast 
enhancement at 1.5 T with conventional dose at 3 T. AJR American journal of 
roentgenology. 2008;190(1):173-7. 
43. Kramer U, Fenchel M, Laub G, et al. Low-dose, time-resolved, contrast-
enhanced 3D MR angiography in the assessment of the abdominal aorta and its major 
branches at 3 Tesla. Academic radiology. 2010;17(5):564-76. 
44. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early 
assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. 
Circulation. 2000;102(14):1678-83. 
45. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion 
recovery for detecting myocardial infarction using gadolinium-delayed 
hyperenhancement. Magnetic resonance in medicine : official journal of the Society 
of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 
2002;47(2):372-83. 
46. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium 
37 
delayed enhancement cardiovascular magnetic resonance correlates with clinical 
measures of myocardial infarction. Journal of the American College of Cardiology. 
2004;43(12):2253-9. 
47. Setser RM, Chung YC, Weaver JA, Stillman AE, Simonetti OP, White RD. 
Effect of inversion time on delayed-enhancement magnetic resonance imaging with 
and without phase-sensitive reconstruction. Journal of magnetic resonance imaging : 
JMRI. 2005;21(5):650-5. 
48. Ishiguchi T, Takahashi S. Safety of gadoterate meglumine (Gd-DOTA) as a 
contrast agent for magnetic resonance imaging: results of a post-marketing 
surveillance study in Japan. Drugs in R&D. 2010;10(3):133-45. 
49. Idee JM, Port M, Raynal I, Schaefer M, Le Greneur S, Corot C. Clinical 
and biological consequences of transmetallation induced by contrast agents for 
magnetic resonance imaging: a review. Fundamental & clinical pharmacology. 
2006;20(6):563-76. 
50. Deray G, Rouviere O, Bacigalupo L, et al. Safety of meglumine gadoterate 
(Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic 
kidney disease (RESCUE study). European radiology. 2013;23(5):1250-9. 
51. Herborn CU, Honold E, Wolf M, et al. Clinical safety and diagnostic value 




국 문 초 록 
 
목적: 3 T 자기공명 영상 장치는 1.5 T 와 비교하여 우월한 신호 대 
잡음 비와 더 길어진 정상 심근의 T1 이완 시간 덕분에 조영제의 양을 
줄이더라도 고식적인 이중 용량을 쓴 1.5 T 자기공명 지연 조영 영상과 
대등한 정도의 영상의 질을 제공할 수 있을 것이라는 예상이 되고 있다. 
그러므로 이 연구에서는 단일 용량의 조영제를 사용하여 시행한 3 T 
자기공명 지연 조영 영상을 고식적 이중 용량 조영제를 사용하여 시행한 
1.5 T 자기공명 지연 조영 영상과 영상의 질을 비교하였다. 
방법: 이 전향적 연구에서는 만성 심근 경색으로 진단 받은 총 10명의 
환자 (남:여= 8:2; 평균연령, 62.5 ± 11.8 세) 를 대상으로 이중 용량의 
조영제를 쓴 1.5 T 자기공명 영상을 획득한 후 이주일 이내에 단일 
용량의 조영제를 사용한 3 T 자기공명 영상 검사를 시행하였다. 
가돌리늄 조영제 (유니레이, 동국제약) 를 주입한 후 대표적인 한 개의 
단축면 영상에 대해서 세 시점에서 (10분, 15분, 20분) 영상을 
획득하였다. 경색 심근과 정상 심근의 대조 잡음 비와 경색 심근과 
좌심실 내강 사이의 대조 잡음 비를 각각의 촬영 시점에서 개인 내에 
비교를 하여 산출 하였다. 또한 두 관찰자가 각각 반자동 정량분석 
프로그램으로 정상 심근과 6-표준편차 기준으로 심근경색 크기를 
정량화 하였고, 급내 상관 계수 측정을 통하여 관찰자 간의 재현성을 
평가하였다. 
결과: 3 T 자기공명 영상에서 단일 조영제만을 사용하였음에도 모든 
39 
정상 또는 경색 심근과 심실 내강의 신호 강도가 이중 용량의 조영제를 
사용하였을 때 보다 두 배 가량 높은 신호 강도를 보였다. 3 T 단일 
조영제를 사용한 지연 조영 증강 영상에서 경색 심근과 정상 심근 간의 
대조 잡음 비는 모든 촬영 시간 대에서 유의한 차이가 없었다. (모두, p > 
0.05). 경색 심근과 좌심실 내강 사이의 대조 잡은 비는 10분 촬영에서 
3 T 자기공명 지연 영상이 이중 용량을 사용한 1.5 T 영상 보다 
유의하게 높은 결과를 보여주었으나(12.4 ± 8.2 대 7.6 ± 4.5, p = 0.049) 
15분과 20분 촬영 영상에서는 유의한 차이가 없었다. 경색 크기의 
정량화 결과는 두 관찰자 간에 1.5 T 와 3 T 에서 유의한 차이가 
없었다 (모두, p > 0.05). 관찰자 간의 재현성은 3 T 단일 용량 조영제 
급내 상관계수 범위: 0.962-0.968) 를 사용하였을 때 통계적으로 
유의하게 모든 시간 대에서 이중용량을 사용한 1.5 T MR (급내 
상관계수 범위: 0.769-0.866) 에 비해 우수하였다. 
결론: 단일 용량의 조영제를 사용하여 시행한 3 T 자기공명 지연 조영 
영상은 좌심실 내강 또는 정상 심근으로부터 경색 심근의 윤곽을 
구분하는 데에는 이중 용량 조영제를 사용하여 시행한 1.5 T 자기공명 
지연 조영 영상보다 우월하다는 결과를 보여주었다. 그러므로 3 T 
자기공명 지연 조영 영상은 신원성 전신 섬유증의 위험을 감소시킬 뿐만 
아니라 경색 심근의 감별에 도움을 줄 수 있을 것으로 기대한다.  
---------------------------------------- 
주요어: 심근경색, 자기공명 영상, 3 테슬라, 조영제, 가돌리늄, 영상의 질, 
경색 크기 
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